Topline results from the Phase III DESTINY-Breast11 trial show that Enhertu (trastuzumab deruxtecan) followed by paclitaxel, ...

Expect to initiate a Phase 1/2a trial in the U.S. in advanced KRAS G12D mutant solid tumors in mid-2025 Initial safety and efficacy results from the trial of VS-7375 by partner GenFleet Therapeutics ...

Phase 1 trial of TGW101 in advanced solid tumors is enrolling to assess safety and pharmacokinetics and define the maximum tolerated dose in up to 50 patients. The FDA granted clearance to the ...

The person would then also receive a corresponding certificate. A rapid test is also normally sufficient to 'test yourself clear' at the end of an infection phase. PCR tests would then only be ...

On this account, we have formulated a chemical composition to synthesize the pure cancrinite (CAN) phase through solid-state transformation and subsequently conducted a comprehensive time-lapsed study ...

of RB-164™ in participants with hematologic cancers such as lymphoma and advanced solid tumors that are associated with high ROR-1 expression. The Phase 1 clinical trial initiates with dose escalation ...

Water molecules in this phase are predicted to remain locked in a crystalline structure but retain the ability to rotate freely, creating a peculiar hybrid between solid and liquid. We used ...

Department of Thermal Science and Energy Engineering, University of Science and Technology of China (USTC), Hefei 230026, Anhui, China ...

The strength of evidence is solid, supported by the multicenter phase II trial design ... absence of pathological complete response (pCR) after neoadjuvant therapy; presence of pCR after neoadjuvant ...